M. Guyot

Neuroelectronics Research Flanders — Belgium

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

12h-index677citations30works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Solubulity and Delivery Systems(7), Advanced Drug Delivery Systems(6), Heparin-Induced Thrombocytopenia and Thrombosis(4), Epilepsy research and treatment(3), Plant Reproductive Biology(3)

Publications30 total

Protocol for closed-loop optogenetic manipulation of cortical activity following hippocampal sharp-wave ripples in freely behaving rats
STAR Protocols·2025· 2 citedOpen Access
Silva Numerica: apprendre la forêt par simulation
Forêt entreprise·2019
A novel drug screening approach to identify new drug candidates for the treatment of Duchenne muscular dystrophy
Neuromuscular Disorders·2017
Fixed artesunate–amodiaquine combined pre-formulation study for the treatment of malaria
International Journal of Pharmaceutics·2010· 20 cited
Comparative in vitro–in vivo study of two quinine rectal gel formulations
International Journal of Pharmaceutics·2004· 41 cited
Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol
International Journal of Pharmaceutics·2000· 118 cited
Nifedipine loaded-polymeric microspheres: preparation and physical characteristics
International Journal of Pharmaceutics·1998· 77 cited
In vitro release of theophylline from cross-linked gelatin capsules
International Journal of Pharmaceutics·1996· 11 cited
Disposition and protective effect against irritation after intravenous and rectal administration of indomethacin loaded nanocapsules to rabbits
International Journal of Pharmaceutics·1996· 23 cited
Bioavailability of norfloxacin from PEG 6000 solid dispersion and cyclodextrin inclusion complexes in rabbits
International Journal of Pharmaceutics·1996· 35 cited
Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions
International Journal of Pharmaceutics·1995· 124 cited
[Present and future choice of pharmaceutical forms for intravaginal administration. II. Barrier systems and vaginal rings].
PubMed·1994
[Present and future choices of vaginal drug dosage forms. I. Classical forms].
PubMed·1994· 6 cited
Influence of Poly(DL-Lactide) Nanocapsules on the Biliary Clearance and Enterohepatic Circulation of Indomethacin in the Rabbit
Pharmaceutical Research·1993· 41 cited
[Artificial blood: the future of blood transfusion? II. Blood substitutes other than hemoglobin solutions].
PubMed·1990
[Artificial blood: the future of blood transfusion? I. Hemoglobin solutions].
PubMed·1990
Laboratory Control of Heparin and Heparin Fragment Treatment: An Experimental Study
Seminars in Thrombosis and Hemostasis·1989· 1 cited
Could thrombus age be a modulator of heparin or L.M.W.H activities ?
Thrombosis Research·1989· 5 cited
Comparative pharmacology of low molecular weight heparins : Implications of manufacturing processes on biological effects
Thrombosis Research·1989· 6 cited
Antithrombotic activity of recombinant hirudin in the rat: A comparative study with heparin
Thrombosis Research·1989· 16 cited
page 1 of 2Next →

Frequent Co-authors

F Fawaz(9), Christian Doutremépuich(6), A.M. Lagueny(5), Magalie Lalanne(4), F. Doutremepuich(4), F. Bonini(3), Eric Deharo(3), O. De Sèze(3), J. Bildet(2), A Brachet‐Liermain(2), P Loiseau(2), Pascal Millet(2), Fawaz Fawaz(2), François Bonini(2), Hatem Fessi(2), M. Maury(2), C. Doutremepuich(2), Jeanine M. Walenga(2), Jawed Fareed(2), F Toulemonde(2)